• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

辅助性实验性放射免疫疗法和热腹腔内化疗对大鼠腹膜癌减瘤手术后肠道和腹部愈合的影响。

The effects of adjuvant experimental radioimmunotherapy and hyperthermic intraperitoneal chemotherapy on intestinal and abdominal healing after cytoreductive surgery for peritoneal carcinomatosis in the rat.

作者信息

Aarts F, Bleichrodt R P, de Man B, Lomme R, Boerman O C, Hendriks T

机构信息

Department of Surgery, Radboud University Nijmegen Medical Centre, Nijmegen, PO Box 9101, 6500 HB Nijmegen, The Netherlands.

出版信息

Ann Surg Oncol. 2008 Nov;15(11):3299-307. doi: 10.1245/s10434-008-0070-4. Epub 2008 Aug 19.

DOI:10.1245/s10434-008-0070-4
PMID:18712445
Abstract

BACKGROUND

Cytoreductive surgery (CS) followed by hyperthermic intraperitoneal chemotherapy (HIPEC) results in limited survival benefit and high morbidity and mortality rates in patients with peritoneal carcinomatosis (PC). Radioimmunotherapy (RIT) after CS of experimental PC has been shown to increase survival and compare favorably to HIPEC. The effects of RIT and HIPEC on wound healing after CS need to be determined.

METHODS

PC was induced by intraperitoneal inoculation of CC-531 colon carcinoma cells in Wag/Rij rats. Animals were subjected to CS and anastomotic construction only or followed by RIT or HIPEC. RIT consisted of 74 MBq (177)lutetium-labeled anti-CC531 antibody MG1. HIPEC was performed by a closed abdominal perfusion technique using mitomycin-C during 60 minutes. Anastomotic and abdominal wall strength measurements were performed 3 and 5 days after surgery.

RESULTS

At day 5, bursting pressure in ileum and colon anastomoses in the CS + HIPEC group, but not in the CS + RIT group, was lower (P < .01) than in the CS group. In the CS group, the colonic bursting site was more often outside the true anastomotic area (8 of 12 animals) than in the CS + HIPEC (1 of 12) and CS + RIT (5 of 12) groups. Abdominal wall strength in the CS + HIPEC group was significantly (P < .01) lower, at both measuring points, than that in both the CS group and the CS + RIT group. There was no difference between the latter.

CONCLUSION

As adjuvant to CS, HIPEC showed a decrease in anastomotic and abdominal wall wound strength in a model of PC of CRC, whereas RIT did not.

摘要

背景

细胞减灭术(CS)联合热灌注化疗(HIPEC)对腹膜癌(PC)患者的生存获益有限,且发病率和死亡率较高。实验性PC患者在CS后进行放射免疫治疗(RIT)已显示可提高生存率,且与HIPEC相比具有优势。需要确定RIT和HIPEC对CS后伤口愈合的影响。

方法

通过向Wag/Rij大鼠腹腔内接种CC-531结肠癌细胞诱导PC。动物仅接受CS和吻合口构建,或随后接受RIT或HIPEC。RIT包括74 MBq的(177)镥标记抗CC531抗体MG1。HIPEC采用闭腹灌注技术,在60分钟内使用丝裂霉素-C进行。在术后3天和5天进行吻合口和腹壁强度测量。

结果

在第5天,CS + HIPEC组回肠和结肠吻合口的破裂压力低于CS组(P <.01),而CS + RIT组则不然。在CS组中,结肠破裂部位更多位于真正吻合口区域之外(12只动物中有8只),而CS + HIPEC组(12只动物中有1只)和CS + RIT组(12只动物中有5只)则较少。在两个测量点,CS + HIPEC组的腹壁强度均显著低于CS组和CS + RIT组(P <.01)。后两者之间没有差异。

结论

作为CS的辅助治疗,在结直肠癌PC模型中,HIPEC显示吻合口和腹壁伤口强度降低,而RIT则没有。

相似文献

1
The effects of adjuvant experimental radioimmunotherapy and hyperthermic intraperitoneal chemotherapy on intestinal and abdominal healing after cytoreductive surgery for peritoneal carcinomatosis in the rat.辅助性实验性放射免疫疗法和热腹腔内化疗对大鼠腹膜癌减瘤手术后肠道和腹部愈合的影响。
Ann Surg Oncol. 2008 Nov;15(11):3299-307. doi: 10.1245/s10434-008-0070-4. Epub 2008 Aug 19.
2
A comparison between radioimmunotherapy and hyperthermic intraperitoneal chemotherapy for the treatment of peritoneal carcinomatosis of colonic origin in rats.大鼠结肠源性腹膜癌病的放射免疫疗法与热腹腔内化疗的比较。
Ann Surg Oncol. 2007 Nov;14(11):3274-82. doi: 10.1245/s10434-007-9509-2. Epub 2007 Jul 25.
3
Timing of adjuvant radioimmunotherapy after cytoreductive surgery in experimental peritoneal carcinomatosis of colorectal origin.结直肠癌源性实验性腹膜癌减瘤手术后辅助性放射免疫治疗的时机
Ann Surg Oncol. 2007 Feb;14(2):533-40. doi: 10.1245/s10434-006-9247-x. Epub 2006 Nov 23.
4
Histological response of peritoneal carcinomatosis after hyperthermic intraperitoneal chemoperfusion (HIPEC) in experimental investigations.实验研究中腹腔热灌注化疗(HIPEC)后腹膜癌转移的组织学反应
BMC Cancer. 2006 Jun 22;6:162. doi: 10.1186/1471-2407-6-162.
5
Radioimmunotherapy is an effective adjuvant treatment after cytoreductive surgery of experimental colonic peritoneal carcinomatosis.放射免疫疗法是实验性结肠腹膜癌减瘤手术后的一种有效辅助治疗方法。
J Nucl Med. 2006 Nov;47(11):1867-74.
6
Intraoperative versus early postoperative intraperitoneal chemotherapy after cytoreduction for colorectal peritoneal carcinomatosis: an experimental study.细胞减灭术后腹腔内化疗与术后早期腹腔内化疗治疗结直肠腹膜转移癌的比较:一项实验研究。
Ann Surg Oncol. 2012 Jul;19 Suppl 3:S475-82. doi: 10.1245/s10434-011-1984-9. Epub 2011 Aug 12.
7
Treatment of peritoneal carcinomatosis from colonic cancer by cytoreduction, peritonectomy and hyperthermic intraperitoneal chemotherapy (HIPEC). Experience of ten years.结直肠癌腹膜转移的细胞减灭术、腹膜切除术和腹腔热灌注化疗(HIPEC)治疗。十年经验。
In Vivo. 2010 Jan-Feb;24(1):79-84.
8
Advanced gastric cancer with or without peritoneal carcinomatosis treated with hyperthermic intraperitoneal chemotherapy: a single western center experience.伴有或不伴有腹膜转移的进展期胃癌接受腹腔热灌注化疗的单中心西方经验。
Eur J Surg Oncol. 2008 Nov;34(11):1246-52. doi: 10.1016/j.ejso.2007.12.003. Epub 2008 Jan 28.
9
Intraoperative hyperthermic intraperitoneal chemotherapy after cytoreductive surgery for peritoneal carcinomatosis in an experimental model.腹腔热灌注化疗在细胞减灭术后腹膜转移瘤实验模型中的应用。
Br J Surg. 2010 Dec;97(12):1874-80. doi: 10.1002/bjs.7249. Epub 2010 Aug 30.
10
Hyperthermia and fibrinolytic therapy do not improve the beneficial effect of radioimmunotherapy following cytoreductive surgery in rats with peritoneal carcinomatosis of colorectal origin.对于结直肠癌源性腹膜癌病大鼠,在减瘤手术后,热疗和纤维蛋白溶解疗法并不能提高放射免疫疗法的有益效果。
Cancer Biother Radiopharm. 2008 Jun;23(3):301-9. doi: 10.1089/cbr.2007.0455.

引用本文的文献

1
Safety of BromAc with Mitomycin C during hyperthermic intraperitoneal chemotherapy (HIPEC): a preclinical study.丝裂霉素C联合溴己新在腹腔热灌注化疗(HIPEC)中的安全性:一项临床前研究。
Am J Cancer Res. 2025 Mar 15;15(3):1213-1223. doi: 10.62347/HQJH9945. eCollection 2025.
2
Radioimmunotherapy for peritoneal carcinomatosis: Preclinical proof of concept to clinical translation.腹膜癌的放射免疫疗法:从临床前概念验证到临床转化
Cell Rep Med. 2025 Apr 15;6(4):102040. doi: 10.1016/j.xcrm.2025.102040. Epub 2025 Mar 27.
3
Comparison of EPIC Versus HIPEC in the Treatment of Colorectal Peritoneal Metastases and Appendix Tumors Using Inverse Probability of Treatment Weighting.
采用逆概率治疗加权法比较 EPIC 与 HIPEC 治疗结直肠腹膜转移和阑尾肿瘤的疗效。
Ann Surg Oncol. 2024 Oct;31(10):7111-7121. doi: 10.1245/s10434-024-15674-2. Epub 2024 Jul 29.
4
The 2022 PSOGI International Consensus on HIPEC Regimens for Peritoneal Malignancies: HIPEC Technologies.2022 年 PSOGI 国际腹膜恶性肿瘤 HIPEC 方案共识:HIPEC 技术。
Ann Surg Oncol. 2024 Oct;31(10):7090-7110. doi: 10.1245/s10434-024-15513-4. Epub 2024 Jul 22.
5
Amplifying Curcumin's Antitumor Potential: A Heat-Driven Approach for Colorectal Cancer Treatment.增强姜黄素的抗肿瘤潜力:一种用于结直肠癌治疗的热驱动方法。
Onco Targets Ther. 2024 Jan 30;17:63-78. doi: 10.2147/OTT.S448024. eCollection 2024.
6
Establishment of an Experimental System for Intraperitoneal Chemotherapy in a Rat Model.建立大鼠模型腹腔化疗的实验体系。
In Vivo. 2021 Sep-Oct;35(5):2703-2710. doi: 10.21873/invivo.12554.
7
Preclinical In Vivo-Models to Investigate HIPEC; Current Methodologies and Challenges.用于研究腹腔热灌注化疗的临床前体内模型;当前方法与挑战
Cancers (Basel). 2021 Jul 8;13(14):3430. doi: 10.3390/cancers13143430.
8
Effect and safety of intraoperative intraperitoneal chemotherapy on patients suffering from colorectal cancer.术中腹腔内化疗对结直肠癌患者的疗效及安全性
World J Surg Oncol. 2021 Mar 22;19(1):84. doi: 10.1186/s12957-021-02197-3.
9
The effects of platelet-rich-plasma gel application to the colonic anastomosis in hyperthermic intraperitoneal chemotherapy: An experimental rat model.富血小板血浆凝胶在高热腹腔化疗中应用于结肠吻合口的效果:实验大鼠模型。
Int Wound J. 2019 Dec;16(6):1426-1432. doi: 10.1111/iwj.13207. Epub 2019 Aug 25.
10
Biological mesh is a safe and effective method of abdominal wall reconstruction in cytoreductive surgery for peritoneal malignancy.生物补片是腹膜恶性肿瘤细胞减灭术中腹壁重建的一种安全有效的方法。
BJS Open. 2018 Aug 2;2(6):464-469. doi: 10.1002/bjs5.93. eCollection 2018 Dec.